ARCHIVES

Trifluridine and Tipiracil Hydrochloride Increase OS, PFS in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Senate Bill Includes $10 Billion for NIH

February 6, 2009

Harvard’s DePinho Becomes Finalist at MD Anderson

May 20, 2011

Resource Offered for DNA Probe Mapping

August 14, 1987

NCI grants funding: Institute Contemplates Increase In RFA Support Due to Large Number Of Grant Applications

July 9, 1999

Zeneca Says NSABP Was Tardy In Reporting Uterine Cancer Deaths

June 24, 1994

In Brief: Salmon, Fidler Head ASCO, AACR; Durant, Pardee Presidents Elect; Namovicz, Other AOs Promoted

May 25, 1984